StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle testing volumes and daily schedule

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jan 24, 2022 2:01pm

408 Views

Post# 34354158

RE:RE:RE:RE:RE:Aristotle testing volumes and daily schedule

Gojotv could not find his arsz with both hands.

Liked2Think wrote: you have been saying its a "buying opportunity" ever since $1.10

you have never been right

how is it clearly booking more than 15 a day? Why? because you say so?

Its obvious the webpage is just the start for internet bookings. WTF does that even mean. you mean a webpage for online bookings is "obviously a website for online bookings". Talk about a worthless sentence.

you people talk as if you have a clue what goes on with this company even though the company never tells investors squat. your all liars.